ReShape Lifesciences (RSLS) executive Bandy sold 294,494 shares for $851K at $2.89

Insider transactions reported

Barton P. Bandy (executive at ReShape Lifesciences Inc., RSLS) reported that they sold 294,494 shares for $851K at $2.89, and received 1,186,006 shares between Jul 22, 2021 and Sep 10, 2021. After these transactions the filing shows 891,512 shares held directly.

Reporting person

Bandy Barton P.

Holdings before and after

• Common Stock, $0.001 par value per share: 0 to 891,512 direct

Footnotes from the filing

1. 1. These shares will vest and be issued with respect to 480,050 shares on July 22, 2021 and the remaining shares vesting monthly thereafter for 36 months pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
2. 2. These shares will vest and be issued monthly over 36 months beginning on July 22, 2021 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
3. 3. These shares were sold to cover taxes in connection with the vesting of restricted stock units.
4. 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.88 to $2.90, inclusive. The Reporting Person undertakes to provide to ReShape Lifesciences Inc., any security holder of ReShape Lifesciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Transaction codes in this filing

Open-market sale:

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ